Radiation oncology as a profession is in a period of retrenchment due to the economic crisis. There is also a growing demand from payors to show value for these treatments, said ASTRO President Anthony Zeitman, M.D. He says the technologies used need to undergo rigorous clinical testing to show what works best and what is most cost-effective. Part of ASTRO's push is for a national registry to help advance this data collection.
Related Content
News | Imaging Software Development
June 12, 2025 — GE HealthCare has announced the combination of GE HealthCare’s proprietary features and algorithms with ...
June 12, 2025 
News | Radiation Therapy
May 14, 2025 — Siemens Healthineers is investing $150 million in new projects to expand production, create jobs and ...
May 15, 2025 
News | Radiation Oncology
May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...
May 03, 2025 
News | Radiology Education
April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...
April 21, 2025 
News | Radiology Business
April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...
April 17, 2025 
News | ASTRO
March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...
March 17, 2025 
News | Computed Tomography (CT)
Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...
November 13, 2024 
News
Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...
August 09, 2024 
News | Radiology Business
July 31, 2024 — The American Registry of Radiologic Technologists (ARRT) announced the three Registered Technologists (R ...
July 31, 2024 
News | PET-CT
July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...
July 31, 2024